Stock-based compensation decreased 40.8%
Stock-based compensation changed -40.8% from the comparable as-filed period.
$9.7M→$5.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CRCT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory decreased 21.0%
Inventory changed -21.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$140.9M→$111.3M4 prior comparisons
Revenue decreased 9.2%
Revenue changed -9.2% from the comparable as-filed period.
$172.1M→$156.3M2 prior comparisons
SBC / revenue moved 196 bp lower
SBC / revenue changed -196 basis points from the comparable as-filed period.
5.63%→3.67%2 prior comparisons
Cash & equivalents decreased 10.4%
Cash & equivalents changed -10.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$298.1M→$266.9M4 prior comparisons
Gross profit increased 14.6%
Gross profit changed +14.6% from the comparable as-filed period.
$101.5M→$116.4M2 prior comparisons
Receivables / revenue moved 150 bp lower
Receivables / revenue changed -150 basis points from the comparable as-filed period.
47.64%→46.13%2 prior comparisons
R&D / revenue moved 105 bp higher
R&D / revenue changed +105 basis points from the comparable as-filed period.
9.74%→10.79%2 prior comparisons
Research & development increased 0.6%
Research & development changed +0.6% from the comparable as-filed period.
$16.8M→$16.9M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.